- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05567965
Live Better at Home in Catalonia (VMCat)
Live Better at Home (Catalonia): a Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
According to recent surveys, more than 80% of older people prefer to live at home, so the current model of care should aim to prolong the autonomy of older people so that they remain as long as possible at home and delay their entry into nursing homes.
The hypothesis of the study is that an intensification of the home care intervention in users with degree II or III of dependency will delay or avoid their institutionalisation in nursing homes.
The main aim of the study is to evaluate the effect of an intensification in home care interventions on users with grade II or III dependency in order to delay or avoid their institutionalisation in a geriatric residence.
Secondary aims are to analyse the effect of an intensification of home care interventions in users with degree II or III of dependency on their health and psychosocial state.To analyse the effect of an intensification of home care intervention together with training for informal caregivers on the health status and overburden of informal caregivers of users with degree II or III of dependency.
To test the impact on the use of resources of an intensification of home care interventions in users with degree II or III of dependency.
A randomised clinical trial with two parallel arms and blinded assessment will be conducted. The duration of follow-up will be 18 months. It will be carried out at the community level in homes in eight municipalities in the province of Barcelona, Catalonia (Spain).
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Eduard Minobes
- Phone Number: +34659350407
- Email: eduard.minobes@segg.es
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Older people (men and women aged 65 and over).
- Living in the community.
- Categorized with a degree II or III of dependency.
- Users of the public home care without requesting admission to an institution in Catalonia.
- With a main informal caregiver in charge.
- The acceptance to participate in the study of the user and the informal caregiver.
Exclusion Criteria:
- Users with privately paid professional carers.
- Users in palliative care (short life expectancy).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intensified home care intervention + Training
Users will receive an intensification in their home care intervention for dependence, receiving an intervention of a minimum of 1 hour per day and a maximum of 3.5 hours, to support their activities of daily living.
The intensification will be personalised according to the specific needs of the user that the professionals consider necessary to attend.
The weekly distribution of the intervention will be flexible in terms of timetables, as agreed between professional and informal caregivers.
In addition, each informal caregiver will receive multimodal online training with the aim of providing knowledge, skills and attitudes that empower them to face the challenge of caring, guaranteeing quality care, preventing situations that may negatively affect both the person and the family dynamics and enabling an optimal evolution in caregiving.
|
The duration of the intervention, both for the control group and the intervention group, will be 18 months or until the user's admission to the nursing home.
|
|
Active Comparator: Conventional home care intervention
Participants will continue with their conventional home care intervention for dependence, comprising activities that are mainly carried out at the users' home and are oriented towards supporting their activities of daily living.
This intervention is of personalised attention and its average intensity is about 20 minutes per day.
|
The duration of the intervention, both for the control group and the intervention group, will be 18 months or until the user's admission to the nursing home.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in time from baseline until application for nursing home admission
Time Frame: Every month up to 18 months. Assessed from the baseline in the study until the application for entry in nursing home, assessed up to 18 months.
|
To the user.
Assessed by asking.
|
Every month up to 18 months. Assessed from the baseline in the study until the application for entry in nursing home, assessed up to 18 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Functional capacity
Time Frame: Every 3 months up to 18 months.
|
To the user.
Assessed by the Barthel Index.
The scoring range is 0 (total dependency)-100 (slight dependency)
|
Every 3 months up to 18 months.
|
|
Frailty
Time Frame: Every 3 months up to 18 months.
|
To the user.
Assessed by the Frail-VIG index.
The scoring range is 0 (no frailty)- 25 (advanced frailty).
|
Every 3 months up to 18 months.
|
|
Risk of sarcopenia
Time Frame: Every 3 months up to 18 months.
|
To the user.
Assessed by the strength, assistance with walking, rising from a chair, climbing stairs, and falls (SARC-F) questionnaire.
The scoring range is 0 - 10 (more than 4 points means risk of sarcopenia).
|
Every 3 months up to 18 months.
|
|
Risk of falls
Time Frame: Every 3 months up to 18 months.
|
To the user.
Assessed by the Downton Scale.
The scoring range is 0 - 14 (more than 3 points means risk of falls).
|
Every 3 months up to 18 months.
|
|
Cognitive status
Time Frame: Every 3 months up to 18 months.
|
To the user.
Assessed by the Reisberg Global Deterioration Scale.
The scoring range is 1 (no dementia)- 7 (late-stage dementia).
|
Every 3 months up to 18 months.
|
|
Social network
Time Frame: Every 3 months up to 18 months.
|
To the user.
Assessed by the Lubben Social Network Scale.
The scoring range is 0 (less social engagement)- 30 (more social engagement).
|
Every 3 months up to 18 months.
|
|
Chronic patient experience
Time Frame: Every 3 months up to 18 months.
|
To the user.
Assessed by the Chronic Patient Experince Evaluation Instrument (IEXPAC).
The scoring range is 0 (worst experience)- 110 (best experience).
|
Every 3 months up to 18 months.
|
|
Quality of life related with health
Time Frame: Every 1 month up to 18 months.
|
To the user.
Assessed by the EUROQOL-5D-3L.
The scoring range is 0 (worst quality of life)- 100 (best quality of life).
|
Every 1 month up to 18 months.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical activity grade
Time Frame: Every 3 months up to 18 months.
|
To the informal caregiver.
Assessed by the International Physical Activity Questionnaire-Short Form (IPAQ).
The classification ranges from low level of physical activity to high level of physical activity.
|
Every 3 months up to 18 months.
|
|
Caregiver overburden
Time Frame: Every 3 months up to 18 months.
|
To the informal caregiver.
Assessed by the Zarit Burden Scale.
The scoring range is 5 (no overburden)- 35 (more overburden).
|
Every 3 months up to 18 months.
|
|
Experience of the informal caregiver with people with chronic disease
Time Frame: Every 3 months up to 18 months.
|
To the informal caregiver.
Assessed by the Chronic Patient Experince Evaluation Instrument for caregivers(IEXPAC caregivers).
The scoring range is 0 (worst experience)- 120 (best experience).
|
Every 3 months up to 18 months.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jose Augusto García Navarro, Spanish Society of Geriatrics and Gerontology
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- VMCCat1.0
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Geriatrics
-
KTO Karatay UniversityCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Universitas PadjadjaranCompletedGeriatrics RehabilitationIndonesia
-
Hospices Civils de LyonCompleted
-
Istanbul University - Cerrahpasa (IUC)Completed
-
University Hospital, LilleCompleted
-
Jewish General HospitalActive, not recruiting
-
GenfitCompleted
-
Centre Francois BaclesseCompleted
-
Centre Hospitalier Universitaire DijonWithdrawn
Clinical Trials on Home care intervention
-
University Health Network, TorontoRecruitingLymphoma | Lymphoproliferative Disorders | Breast Cancer Stage I | Breast Cancer Stage II | Colorectal Cancer Stage II | Colorectal Cancer Stage III | Breast Cancer Stage III | Colorectal Cancer Stage I | Head and Neck Cancer Stage III | Breast Cancer, Stage 0 | Head and Neck Cancer Stage I | Head and Neck Cancer...Canada
-
The University of Hong KongCompletedFrailty | GeriatricsHong Kong
-
University of UtahCompletedOncologyUnited States
-
Baylor College of MedicineM.D. Anderson Cancer Center; Harris County Hospital District; Texas A&M University and other collaboratorsCompleted
-
Medical College of WisconsinRecruitingType 2 DiabetesUnited States
-
Shepherd Center, Atlanta GAUnknownBrain Injuries, TraumaticUnited States
-
University GhentInBev-Baillet Latour Fund; Baluchon Alzheimer Belgium vzwCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Vanderbilt Office of Clinical and Translational...TerminatedHead and Neck Cancer | LymphedemaUnited States
-
US Department of Veterans AffairsCompletedCerebrovascular AccidentUnited States
-
Universidade Cidade de Sao PauloUnknown